Morgan Joseph & Co.

The U.S. airplane bomb scare had a negative impact on stocks today. However, there are certain sectors such as security instrument and identity management, which are likely to benefit from this incident. Talking to CNBC, Arnie Ursaner of CJS Securities favored American Science & Engineering...

Morgan Joseph & Co. have reiterated their "Buy" rating for ISIS Pharmaceuticals, Inc. (NASDAQ: ISIS) and has target price for ISIS of $18, which is a premium of over 60% from its yesterday’s closing price of $11.12. Yesterday, Isis Pharmaceuticals reported encouraging results with a...